ethacizine
Sign in to saveAlso known as Diaethylaminopropyonylaethoxycarbonylaminophenothiazinum, Аеthacizinum, Ethacizinum
Ethacizine (ethacyzine) is a class Ic antiarrhythmic agent, related to moracizine. It is used in Russia and some other CIS countries for the treatment of severe and/or refractory ventricular and supraventricular arrhythmias, especially those accompanied by organic heart disease. It is also indicated as a treatment of refractory tachycardia associated with Wolff–Parkinson–White syndrome.
Research
161 papers- Antiarrhythmic efficacy of ethacizine assessed by programmed electrical stimulation in patients with ventricular tachycardia.Pacing and clinical electrophysiology : PACE · 1992
- [Ethacizine in the treatment of psoriasis].Vestnik dermatologii i venerologii · 1989
- Moracizine and ethacizine effects on membrane receptors.Arzneimittel-Forschung · 1989
- [Comparative evaluation of the effects of ethacizine and Bonnecor in the treatment of supraventricular paroxysmal tachycardia].Kardiologiia · 1991
- [Electrophysiological effects of ethacizine in experimental myocardial infarction and stimulation of sympathetic heart innervation].Eksperimental'naia i klinicheskaia farmakologiia · 2002
via PubMed
~1 min read
Encyclopedic overview
3 sectionsContents
- Synthesis
- See also
- References
Ethacizine (ethacyzine) is a class Ic antiarrhythmic agent, related to moracizine. It is used in Russia and some other CIS countries for the treatment of severe and/or refractory ventricular and supraventricular arrhythmias, especially those accompanied by organic heart disease. It is also indicated as a treatment of refractory tachycardia associated with Wolff–Parkinson–White syndrome.
It is manufactured under the brand name Ethacizin (Этацизин) by Latvian pharmaceutical company Olainfarm. ==Synthesis== For the treatment of heart infarction: thumb|center|501px|Synthesis: Patent:
Excerpted from Wikipedia’s “ethacizine” article, available under the CC BY-SA 4.0 licence.
Available in 8 languages
via Wikidata sitelinks · CC0